Tubulocystic renal cell carcinoma: Is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases

• Main Authors: Steiner, P., Hora, M., Stehlik, J., Martinek, P., Vanecek, T., Petersson, F., Michal, M., Korabecna, M., Travnicek, I., Hes, O.
• 其他作者: PATHOLOGY
• 格式: Article
• 出版: 2016
• 主題: Angiogenic pathways; Antiangiogenic targeted therapy; Kidney; mRNA expression; Protein expression; Tubulocystic renal cell carcinoma
• 在線閱讀: http://scholarbank.nus.edu.sg/handle/10635/125641
• 機構: National University of Singapore

10.1007/s00428-012-1367-z